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Abstract 
Gene set enrichment analyses of 8,405 genes linked with 35,074 human-specific (hs) regulatory single-
nucleotide changes (SNCs) revealed the staggering breadth of significant associations with morphological 
structures, physiological processes, and pathological conditions of Modern Humans. Significant enrichment 
traits include more than 1,000 anatomically-distinct regions of the adult human brain, many different types of 
human cells and tissues, more than 200 common human disorders and more than 1,000 records of rare 
diseases. Thousands of genes connected with regulatory hsSNCs have been identified in this contribution, 
which represent essential genetic elements of the autosomal inheritance and survival of species phenotypes: a 
total of 1,494 genes linked with either autosomal dominant or recessive inheritance as well as 2,273 genes 
associated with premature death, embryonic lethality, as well as pre-, peri-, neo-, and post-natal lethality of 
both complete and incomplete penetrance. Therefore, thousands of heritable traits and critical genes impacting 
the offspring survival appear under the human-specific regulatory control in genomes of Modern Humans. 
These observations highlight the remarkable translational opportunities afforded by the discovery of genetic 
regulatory loci harboring hsSNCs that are fixed in humans, distinct from other primates, and located in 
differentially-accessible (DA) chromatin regions during human brain development.  
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Introduction 
DNA sequences of coding genes defining the structure of macromolecules comprising the essential building 
blocks of life at the cellular and organismal levels remain highly conserved during the evolution of humans and 
other Great Apes (Chimpanzee Sequencing and Analysis Consortium, 2005; Kronenberg et al., 2018). In 
striking contrast, a compendium of nearly hundred thousand candidate human-specific regulatory sequences 
(HSRS) has been assembled in recent years (Glinsky et al., 2015-2019; Kanton et al., 2019), thus validating 
the idea that unique to human phenotypes may result from human-specific changes to genomic regulatory 
sequences defined as “regulatory mutations” (King and Wilson, 1975). The best evidence of the exquisite 
degree of accuracy of the contemporary molecular definition of human-specific regulatory sequences is 
identification of 35,074 single nucleotide changes (SNCs) that are fixed in humans, distinct from other 
primates, and located within differentially-accessible (DA) chromatin regions during the human brain 
development in cerebral organoids (Kanton et al., 2019). However, only a small fraction of identified DA 
chromatin peaks (600 of 17,935 DA peaks; 3.3%) manifest associations with differential expression in human 
versus chimpanzee cerebral organoids model of brain development, consistent with the hypothesis that 
regulatory effects on gene expression of these chromatin regions are not restricted to the early stages of brain 
development. Annotation of SNCs derived and fixed in modern humans that overlap DA chromatin regions 
during brain development revealed that essentially all candidate regulatory human-specific SNCs are shared 
with the archaic humans (35,010 SNCs; 99.8%) and only 64 SNCs are unique to modern humans (Kanton et 
al., 2019). This remarkable conservation on the human lineage of human-specific SNCs associated with 
human brain development sows the seed of interest for in-depth exploration of coding genes expression of 
which may be affected by genetic regulatory loci harboring human-specific SNCs. The GREAT algorithm 
(McLean et al., 2010, 2011) was utilized to identify 8,405 genes expression of which might be affected by 
35,074 human-specific SNCs located in DA chromatin regions during brain development. Comprehensive gene 
set enrichment analyses of these genes revealed the staggering breadth of associations with physiological 
processes and pathological conditions of H. sapiens, including more than 1,000 anatomically-distinct regions of 
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the adult human brain, many human tissues and cell types, more than 200 common human disorders and 
1,116 rare diseases.  
Results and discussion 
Identification and characterization of putative genetic regulatory targets associated with human-
specific single nucleotide changes (SNCs) in in differentially accessible (DA) chromatin regions during 
brain development 
To identify and characterize human genes associated with 35,074 human-specific single nucleotide changes 
(SNCs) in differentially accessible (DA) chromatin regions during human and chimpanzee neurogenesis in 
cerebral organoids (Kanton et al., 2019), the GREAT algorithm (McLean et al., 2011) have been employed. 
These analyses identified 8,405 genes with putative regulatory connections to human-specific SNCs (Figure 1) 
and revealed a remarkable breadth of highly significant associations with a multitude of biological processes, 
molecular functions, genetic and metabolic pathways, cellular compartments, and gene expression 
perturbations (Supplemental Table Set S1).   
It has been noted that particularly striking numbers of significant associations were uncovered by the GREAT 
algorithm during the analyses of two databases:  
1) The Human Phenotype Ontology containing over 13,000 terms describing clinical phenotypic abnormalities 
that have been observed in human diseases, including hereditary disorders (326 significant records with 
binominal FDR Q-Value < 0.05);  
2) The MGI Expression Detected ontology referencing genes expressed in specific anatomical structures at 
specific developmental stages (Theiler stages) in the mouse (370 significant records with binominal FDR Q-
Value < 0.05).  
These observations support the hypothesis that biological functions of genes under the putative regulatory 
control of human-specific SNCs in DA chromatin regions during brain development are not limited to the 
contribution to the early stages of neuro- and corticogenesis. Collectively, findings reported in the 
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Supplemental Table Set S1 argue that genes expression of which is affected by human-specific SNCs may 
represent a genomic dominion of putative regulatory dependency from HSRS that is likely to play an important 
role in a broad spectrum of physiological processes and pathological conditions of Modern Humans.  
Identification of genes expression of which distinguishes thousands of anatomically distinct areas of 
the adult human brain, various regions of the central nervous system, and many different cell types 
and tissues in the human body 
To validate and extend these observations, next the comprehensive gene set enrichment analyses were 
performed employing the web-based Enrichr API protocols (Chen et al., 2013; Kuleshov et al., 2016), which 
interrogated nearly 200,000 gene sets from more than 100 gene set libraries. The results of these analyses are 
summarized in the Table 1 and reported in details in the Supplemental Table Set S2. Genes expression of 
which were placed during evolution under the regulatory control of ~ 35,000 human-specific SNCs 
demonstrate a staggering breadth of significant associations with a broad spectrum of anatomically distinct 
regions, various cell and tissue types, a multitude of physiological processes, and a numerous pathological 
conditions of H. sapiens.   
Of particular interest is the apparent significant enrichment of human-specific SNCs-associated genes among 
both up-regulated and down-regulated genes, expression of which discriminates thousands of anatomically 
distinct areas of the adult human brain defined in the Allen Brain Atlas (Figure 2; Supplemental Table Set S2). 
Notably, genes expressed in various thalamus regions appear frequently among the top-scored anatomical 
areas of the human brain (Figure 2; Supplemental Table Set S2). These observations support the hypothesis 
that genetic loci harboring human-specific SNCs may exert regulatory effects on structural and functional 
features of the adult human brain, thus, likely affecting the development and functions of the central nervous 
system in Modern Humans. Consistent with this idea, the examination of the enrichment patterns of human-
specific SNCs-associated genes in the ARCHS4 Human Tissues’ gene expression database revealed that top 
10 most significantly enriched records overlapping a majority of region-specific marker genes constitute various 
anatomically-distinct regions of the central nervous system (Figure 2; Supplemental Table Set S2). However, 
results of gene set enrichment analyses convincingly demonstrate that inferred regulatory effects of genetic 
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loci harboring human-specific SNCs are not restricted only to the various regions of the central nervous 
system, they appear to affect gene expression profiles of many different cell types and tissues in the human 
body (Table 1; Supplemental Table Set S2).  
Identification and characterization of genes expression of which is altered during aging of humans, 
rats, and mice 
Genes altered expression of which is implicated in the aging of various tissues and organs of humans, rats, 
and mice are significantly enriched among 8,405 genes associated with human-specific regulatory SNCs 
(Figure 3; Supplemental Table Set S2). Aging of the hippocampus was implicated most frequently among 
genes manifesting increased expression with age, while among genes exhibiting aging-associated decreased 
expression the hippocampus and frontal cortex were identified repeatedly (Figure 3). Overall, twice as many 
significant association records were observed among aging-associated down-regulated genes compared to up-
regulated genes (Table 1). Collectively, these observations indicate that genes changes in expression of which 
were associated with aging in mammals, in particular, hippocampal and frontal cortex aging, represent 
important elements of a genomic dominion that was placed under regulatory control of genetic loci harboring 
human-specific SNCs.  
Identification of genes implicated in development and manifestations of hundreds physiological and 
pathological phenotypes and autosomal inheritance in Modern Humans 
Interrogations of the Human Phenotype Ontology database (298 significantly enriched records identified), the 
Genome-Wide Association Study (GWAS) Catalogue (241 significantly enriched records identified), and the 
database of Human Genotypes and Phenotypes (136 significantly enriched records identified) revealed several 
hundred physiological and pathological phenotypes and thousands of genes manifesting significant enrichment 
patterns defined at the adjusted p value < 0.05 (Figure 4; Table 1; Supplemental Table Set S2). Interestingly, 
645 and 849 genes implicated in the autosomal dominant (HP:0000006) and recessive (HP:0000007) 
inheritance were identified amongst genes associated with human-specific regulatory SNCs (Figure 4; 
Supplemental Table Set S2). Notable pathological conditions among top-scored records identified in the 
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database of Human Genotypes and Phenotypes are stroke, myocardial infarction, coronary artery disease, and 
heart failure (Figure 4).  
A total of 241 significantly enriched records (Table 1) were documented by gene set enrichment analyses of 
the GWAS catalogue (2019), among which a highly diverse spectrum of pathological conditions linked to genes 
associated with human-specific regulatory SNCs was identified, including obesity, type 2 diabetes, amyotrophic 
lateral sclerosis, autism spectrum disorders, attention deficit hyperactivity disorder, bipolar disorder, major 
depressive disorder, schizophrenia, Alzheimer’s disease, malignant melanoma, diverticular disease, asthma, 
coronary artery disease, glaucoma, as well as breast, prostate and colorectal cancers (Figure 4; Supplemental 
Table Set S2). These observations indicate that thousands of genes putatively associated with genetic 
regulatory loci harboring human-specific SNCs affect risk of developing numerous pathological conditions in 
Modern Humans.  
Identification of genes expression of which is altered in several hundred common human disorders 
Gene set enrichment analyses-guided interrogation of the Gene Expression Omnibus (GEO) database 
revealed the remarkably diverse spectrum of human diseases with the etiologic origins in multiple organs and 
tissues and highly heterogeneous pathophysiological trajectories of their pathogenesis (Figure 5; Supplemental 
Table Set S2). Overlapping gene sets between disease-associated genes and human-specific SNCs-linked 
genes comprise of hundreds of genes that were either up-regulated (204 significant disease records) or down-
regulated (240 significant disease records) in specific pathological conditions, including schizophrenia, bipolar 
disorder, various types of malignant tumors, Crohn’s disease, ulcerative colitis, Down syndrome, Alzheimer’s 
disease, spinal muscular atrophy, multiple sclerosis, autism spectrum disorders, type 2 diabetes mellitus, 
morbid obesity, cardiomyopathy (Figure 5; Supplemental Table Set S2). These observations demonstrate that 
thousands of genes expression of which is altered in a myriad of human diseases appear associated with 
genetic regulatory loci harboring human-specific SNCs.  
Identification of genes implicated in more than 1,000 records classified as human rare diseases 
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Present analyses demonstrate that thousands of genes associated with human-specific regulatory SNCs have 
been previously identified as genetic elements affecting the likelihood of development a multitude of common 
human disorders. Similarly, thousands of genes expression of which is altered during development and 
manifestation of multiple common human disorders appear linked to genetic regulatory loci harboring human-
specific SNCs. Remarkably, interrogations of the Enrichr’s libraries of genes associated with Modern Humans’ 
rare diseases identified 473, 603, 641, and 1,116 significantly enriched records of various rare disorders 
employing the Rare Diseases GeneRIF gene lists library, the Rare Diseases GeneRIF ARCHS4 predictions 
library, the Rare Diseases AutoRIF ARCHS4 predictions library, and the Rare Diseases AutoRIF Gene lists 
library, respectively (Figure 6; Supplemental Table Set S2). Taken together, these observations demonstrate 
that thousands of genes associated with hundreds of human rare disorders appear linked with human-specific 
regulatory SNCs.  
Gene ontology analyses of putative regulatory targets of genetic loci harboring human-specific SNCs  
Gene Ontology (GO) analyses identified a constellation of biological processes (GO Biological Process: 308 
significant records) supplemented with a multitude of molecular functions (GO Molecular Function: 81 
significant records) that appear under the regulatory control of human-specific SNCs (Figure 7; Supplemental 
Table Set 2). Consistently, both databases identified frequently the components of transcriptional regulation 
and protein kinase activities among most significant records. Other significantly enriched records of interest are 
regulation of apoptosis, cell proliferation, migration, and various binding properties (cadherin binding; 
sequence-specific DNA binding; protein-kinase binding; amyloid-beta binding; actin binding; tubulin binding; 
microtubule binding; PDZ domain binding) which are often supplemented by references to the corresponding 
activity among the enriched records, for example, enriched records of both binding and activity of protein 
kinases.  
Interrogation of GO Cellular Component database identified 29 significantly enriched records, among which 
nuclear chromatin as well as various cytoskeleton and membrane components appear noteworthy (Figure 7). 
Both GO Biological Process and GO Cellular Component database identified significantly enriched records 
associated with the central nervous system development and functions such as axonogenesis and axon 
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guidance; generation of neurons, neuron differentiation, and neuron projection morphogenesis; cellular 
components of dendrites and dendrite’s membrane; ionotropic glutamate receptor complex. In several 
instances biologically highly consistent enrichment records have been identified in different GO databases: 
cadherin binding (GO Molecular Function) and catenin complex (GO Cellular Component); actin binding (GO 
Molecular Function) and actin cytoskeleton, cortical actin cytoskeleton, actin-based cell projections (GO 
Cellular Component); microtubule motor activity, tubulin binding, microtubule binding (GO Molecular Function) 
and microtubule organizing center, microtubule cytoskeleton (GO Cellular Component). 
Analyses of human and mouse databases of the Kyoto Encyclopedia of Genes and Genomes (KEGG; Figure 
8) identified more than 100 significantly enriched records in each database (KEGG 2019 Human (2019): 129 
significant records; KEGG 2019 Mouse: 106 significant records). Genes associated with human-specific 
regulatory SNCs were implicated in a remarkably broad spectrum of signaling pathways ranging from 
pathways regulating the pluripotency of stem cells to cell type-specific morphogenesis and differentiation 
pathways, for example, melanogenesis and adrenergic signaling in cardiomyocytes (Figure 8). Genes under 
putative regulatory control of human-specific SNCs include hundreds of genes contributing to specific functions 
of specialized differentiated cells (gastric acid secretion; insulin secretion; aldosterone synthesis and 
secretion), multiple receptor/ligand-specific signaling pathways, as well as genetic constituents of pathways 
commonly deregulated in cancer and linked to the organ-specific malignancies, for example, breast, colorectal, 
and small cell lung cancers (Figure 8). Other notable entries among most significantly enriched records include 
axon guidance; dopaminergic, glutamatergic, and cholinergic synapses; neuroactive receptor-ligand 
interactions; and AGE-RAGE signaling pathway in diabetic complications (Figure 8; Supplemental Table Set 
2).  
Structurally, functionally, and evolutionary distinct classes of HSRS share the relatively restricted elite 
set of common genetic targets 
It has been suggested that unified activities of thousands candidate HSRS comprising a coherent compendium 
of genomic regulatory elements markedly distinct in their structure, function, and evolutionary origin may have 
contributed to development and manifestation of human-specific phenotypic traits (Glinsky, 2019). It was 
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interest to determine whether genes previously linked to other classes of HSRS, which were identified without 
considerations of human-specific SNCs, overlap with genes associated in this contribution with genomic 
regulatory loci harboring human-specific SNCs. It was observed that the common gene set comprises of 7,406 
coding genes (88% of all human-specific SNCs-associated genes), indicating that structurally-diverse HSRS, 
the evolutionary origin of which has been driven by mechanistically-distinct processes, appear to favor the 
regulatory alignment with the relatively restricted elite set of genetic targets (Figure 9).  
Previous studies have identified stem cell-associated retroviral sequences (SCARS) encoded by human 
endogenous retroviruses LTR7/HERVH and LTR5_Hs/HERVK as one of the significant sources of the 
evolutionary origin of HSRS (Glinsky, 2015-2019), including human-specific transcription factor binding sites 
(TFBS) for NANOG, OCT4, and CTCF (Glinsky, 2015). Next, the common sets of genetic regulatory targets 
were identified for genes expression of which is regulated by SCARS and genes associated in this study with 
human-specific regulatory SNCs (Figure 9). It has been determined that each of the structurally-distinct 
families of SCARS appears to share a common set of genetic regulatory targets with human-specific SNCs 
(Figure 9). Overall, expression of nearly half (4,029 genes; 48%) of all genes identified as putative regulatory 
targets of human-specific SNCs is regulated by SCARS (Figure 9). Consistent with the idea that structurally-
diverse HSRS may favor the relatively restricted elite set of genetic targets, the common gene set of regulatory 
targets for HSRS, SCARS, and SNCs comprises of 7,833 coding genes or 93% of all genes associated in this 
contribution with human-specific regulatory SNCs (Figure 9).  
To gain insights into mechanisms of SCARS-mediated effects on expression of 4,029 genes linked to human-
specific regulatory SNCs, the numbers of genes expression of which was either activated (down-regulated 
following SCARS silencing) or inhibited (up-regulated following SCARS silencing) by SCARS have been 
determined. It was observed that SCARS exert the predominantly inhibitory effect on expression of genes 
associated with human-specific regulatory SNCs, which is exemplified by activated expression of as many as 
87% of genes affected by SCARS silencing (Figure 9).  
Identification of 2,273 genes associated with human-specific SNCs and implicated in premature death 
and embryonic, prenatal, perinatal, neonatal, and postnatal lethality phenotypes 
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Interrogation of MGI Mammalian Phenotype databases revealed several hundred mammalian phenotypes 
affected by thousands of genes associated with genomic regulatory regions harboring human-specific SNCs: 
the MGI Mammalian Phenotype (2017) database identified 749 significant enrichment records, while the MGI 
Mammalian Phenotype Level 4 (2019) database identified 407 significant enrichment records (Figure 10; 
Supplemental Table Set S2). Strikingly, present analyses identified a total of 2,273 genes that are associated 
with premature death, essential for embryonic survival, implicated in prenatal, perinatal, neonatal, and 
postnatal lethality phenotypes of both complete and incomplete penetrance (Figure 11) and appear under 
regulatory control of genetic loci harboring human-specific SNCs. A significant fraction of these 2,273 offspring 
survival genes were implicated in the autosomal dominant (389 genes) and recessive (426 genes) inheritance 
in Modern Humans (Figure 11). Based on these observations, it has been concluded that thousands of genes 
within the genomic dominion of putative regulatory dependency from human-specific SNCs represent the 
essential genetic elements of the survival of species phenotypes.  
Methods 
Data source and analytical protocols 
Candidate human-specific regulatory sequences and African Apes-specific retroviral insertions 
A total of 94,806 candidate HSRS, including 35,074 human-specific SNCs, detailed descriptions of which and 
corresponding references of primary original contributions are reported elsewhere (Glinsky et al., 2015-2019; 
Kanton et al., 2019). Solely publicly available datasets and resources were used in this contribution. The 
significance of the differences in the expected and observed numbers of events was calculated using two-
tailed Fisher’s exact test. Additional placement enrichment tests were performed for individual classes of 
HSRS taking into account the size in bp of corresponding genomic regions.  
 
Data analysis 
Categories of DNA sequence conservation 
Identification of highly-conserved in primates (pan-primate), primate-specific, and human-specific sequences 
was performed as previously described (Glinsky, 2015-2019). In brief, all categories were defined by direct and 
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reciprocal mapping using LiftOver. Specifically, the following categories of candidate regulatory sequences 
were distinguished: 
- Highly conserved in primates’ sequences: DNA sequences that have at least 95% of bases remapped 
during conversion from/to human (Homo sapiens, hg38), chimp (Pan troglodytes, v5), and bonobo (Pan 
paniscus, v2; in specifically designated instances, Pan paniscus, v1 was utilized for comparisons). 
Similarly, highly-conserved sequences were defined for hg38 and latest releases of genomes of Gorilla, 
Orangutan, Gibbon, and Rhesus.  
- Primate-specific: DNA sequences that failed to map to the mouse genome (mm10). 
- Human-specific: DNA sequences that failed to map at least 10% of bases from human to both 
chimpanzee and bonobo. All candidate HSRS identified based on the sequence alignments failures to 
genomes of both chimpanzee and bonobo were subjected to more stringent additional analyses 
requiring the mapping failures to genomes of Gorilla, Orangutan, Gibbon, and Rhesus. These loci were 
considered created de novo human-specific regulatory sequences (HSRS). 
To infer the putative evolutionary origins, each evolutionary classification was defined independently by 
running the corresponding analyses on all candidate HSRS representing the specific category. For example, 
human-rodent conversion identify sequences that are absent in the mouse genome based on the sequence 
identity threshold of 10%). Additional comparisons were performed using the same methodology and exactly 
as stated in the manuscript text and described in details below. 
 
Genome-wide proximity placement analysis 
Genome-wide Proximity Placement Analysis (GPPA) of distinct genomic features co-localizing with HSRS was 
carried out as described previously (Glinsky, 2015-2019). Briefly, a typical example of the analytical protocol is 
described below. The significance of overlaps between hESC active enhances and human-specific 
transcription factor binding sites (hsTFBS) was examined by first identifying all hsTFBS that overlap with any of 
the genomic regions tested in the ChIP-STARR-seq dataset (Barakat etl, 2018; Glinsky et al., 2018-2019). 
Then, the relative frequency of active enhancers overlapping with hsTFBS was calculated. To assess the 
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significance of the observed overlap of genomic coordinates, the values recorded for hsTFBS were compared 
with the expected frequency of active and non-active enhancers that overlap with all TFBS for NANOG (15%) 
and OCT4 (25%) as previously determined (Barakat et al 2018). The analyses demonstrated that more than 
95% of hsTFBS co-localized with sequences in the tested regions of the hESC genome. 
The Enrichr API (January 2018 through October 2019 releases) (Chen et al., 2013; Kuleshov et al., 
2016) was used to test genes linked to HSRS of interest for significant enrichment in numerous functional 
categories. In all tables and plots (unless stated otherwise), the “combined score” calculated by Enrichr is 
reported, which is a product of the significance estimate and the magnitude of enrichment (combined score c = 
log(p) * z, where p is the Fisher’s exact test p-value and z is the z-score deviation from the expected rank). 
When technically feasible, larger sets of genes comprising several thousand entries were analyzed. Regulatory 
connectivity maps between HSRS and coding genes and additional functional enrichment analyses were 
performed with the GREAT algorithm (McLean et al., 2010; 2011) at default settings.  
Statistical Analyses of the Publicly Available Datasets 
All statistical analyses of the publicly available genomic datasets, including error rate estimates, background 
and technical noise measurements and filtering, feature peak calling, feature selection, assignments of 
genomic coordinates to the corresponding builds of the reference human genome, and data visualization, were 
performed exactly as reported in the original publications and associated references linked to the 
corresponding data visualization tracks (http://genome.ucsc.edu/). Any modifications or new elements of 
statistical analyses are described in the corresponding sections of the Results. Statistical significance of the 
Pearson correlation coefficients was determined using GraphPad Prism version 6.00 software. Both nominal 
and Bonferroni adjusted p values were estimated. The significance of the differences in the numbers of events 
between the groups was calculated using two-sided Fisher’s exact and Chi-square test, and the significance of 
the overlap between the events was determined using the hypergeometric distribution test (Tavazoie et al., 
1999).  
 
 
 
 14 
 
Supplemental Information 
Supplemental information includes Supplemental Tables S1 and S2, Supplemental Text, and Supplemental 
Figures. 
 
Author Contributions 
This is a single author contribution. All elements of this work, including the conception of ideas, formulation, 
and development of concepts, execution of experiments, analysis of data, and writing of the paper, were 
performed by the author.  
 
Acknowledgements 
This work was made possible by the open public access policies of major grant funding agencies and 
international genomic databases and the willingness of many investigators worldwide to share their primary 
research data. I would like to thank my anonymous colleagues for their valuable critical contributions during the 
peer review process of this work.  
 
 
 
 
 
 
 
 
 15 
 
References 
Barakat TS, Halbritter F, Zhang M, Rendeiro AF, Perenthaler E, Bock C, Chambers I. 2018. Functional 
dissection of the enhancer repertoire in human embryonic stem cells. Cell Stem Cell. 2018; 23: 276-288.e8. 
doi: 10.1016/j.stem.2018.06.014. Epub 2018 Jul 19.   
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. 2013. Enrichr: interactive 
and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128. doi: 10.1186/1471-
2105-14-128.  
Chimpanzee Sequencing and Analysis Consortium, Initial sequence of the chimpanzee genome and 
comparison with the human genome. 2005. Nature 437, 69–87. 
Glinsky GV. 2015. Transposable elements and DNA methylation create in embryonic stem cells human-
specific regulatory sequences associated with distal enhancers and non-coding RNAs. Genome Biol Evol 7: 
1432-1454.  
Glinsky GV. 2016. Mechanistically distinct pathways of divergent regulatory DNA creation contribute to 
evolution of human-specific genomic regulatory networks driving phenotypic divergence of Homo sapiens. 
Genome Biol Evol 8:2774-88. 
Glinsky GV. 2016. Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-
resistant phenotypes of malignant tumors. Cancer Lett 376:347-359. 
Glinsky GV. 2016. Single cell genomics reveals activation signatures of endogenous SCAR's networks in 
aneuploid human embryos and clinically intractable malignant tumors. Cancer Lett 381:176-93. 
Glinsky GV. 2017. Human-specific features of pluripotency regulatory networks link NANOG with fetal and 
adult brain development. BioRxiv. https://www.biorxiv.org/content/early/2017/06/19/022913; doi: 
https://doi.org/10.1101/022913.   
 16 
 
Glinsky GV. 2018. Contribution of transposable elements and distal enhancers to evolution of human-specific 
features of interphase chromatin architecture in embryonic stem cells. Chromosome Res. 2018. 26: 61-84. 
Glinsky G, Durruthy-Durruthy J, Wossidlo M, Grow EJ, Weirather JL, Au KF, Wysocka J, Sebastiano V. 2018. 
Single cell expression analysis of primate-specific retroviruses-derived HPAT lincRNAs in viable human 
blastocysts identifies embryonic cells co-expressing genetic markers of multiple lineages. Heliyon 4: e00667. 
doi: 10.1016/j.heliyon.2018.e00667. eCollection 2018 Jun. PMID: 30003161. 
Glinsky GV, Barakat TS. 2019. The evolution of Great Apes has shaped the functional enhancers' landscape in 
human embryonic stem cells. 37:101456. PMID: 31100635. DOI: 10.1016/j.scr.2019.101456  
Glinsky GV. 2019. A catalogue of 59,732 human-specific regulatory sequences reveals unique to human 
regulatory patterns associated with virus-interacting proteins, pluripotency and brain development. DNA and 
Cell Biology, in press.  
Guffanti G, Bartlett A, Klengel T, Klengel C, Hunter R, Glinsky G, Macciardi F. 2018. Novel bioinformatics 
approach identifies transcriptional profiles of lineage-specific transposable elements at distinct loci in the 
human dorsolateral prefrontal cortex. Mol Biol Evol. 35: 2435-2453. PMID: 30053206. PMCID: PMC6188555. 
DOI: 10.1093/molbev/msy143. 
Kanton S, Boyle MJ, He Z, Santel M, Weigert A, Sanchís-Calleja F, Guijarro P, Sidow L, Fleck JS, Han D, Qian 
Z, Heide M, Huttner WB, Khaitovich P, Pääbo S, Treutlein B, Camp JG. 2019. Organoid single-cell genomic 
atlas uncovers human-specific features of brain development. Nature. 2019; 574: 418-422. PMID: 31619793; 
DOI: 10.1038/s41586-019-1654-9.   
King MC, Wilson AC. 1975. Evolution at two levels in humans and chimpanzees. Science 188: 107-116. 
https://doi.org/10.1126/science.1090005  
Kronenberg ZN, et al. 2018. High-resolution comparative analysis of great ape genomes. Science 360: 
eaar6343.  
 17 
 
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, 
Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma'ayan A. Enrichr: a comprehensive gene set 
enrichment analysis web server 2016 update. Nucleic Acids Research. 2016; gkw377.  
McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B., Wenger, A.M., Bejerano, G. 2011. 
GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28: 495-501. 
McLean CY, Reno PL, Pollen AA, Bassan AI, Capellini TD, Guenther C, Indjeian VB, Lim X, Menke DB, 
Schaar BT, Wenger AM, Bejerano G, Kingsley DM. 2011. Human-specific loss of regulatory DNA and the 
evolution of human-specific traits. Nature 471: 216-9.  
 
 
 
 
 
 
 
 
 
 
 18 
 
Table 1. Associations with human physiological processes and pathological conditions of 8,405 genes linked 
with 35,074 human-specific single nucleotide changes (SNC) within differentially-accessible (DA) chromatin 
regions identified during human and chimpanzee brain development in cerebral organoids.  
Database Number of significant records* 
ARCHS4 Human Tissues 39 
Human Brain Regions: Allen Brain Atlas (Up-regulated genes) 1,200 
Human Brain Regions: Allen Brain Atlas (Down-regulated genes) 1,062 
Aging Perturbations from GEO (Up-regulated genes) 34 
Aging Perturbations from GEO (Down-regulated genes) 67 
GO Biological Process 308 
GO Molecular Function 81 
GO Cellular Component 29 
KEGG 2019 Human 129 
KEGG 2019 Mouse 106 
MGI Mammalian Phenotype 2017 749 
MGI Mammalian Phenotype Level 4 2019 407 
Human Phenotype Ontology 298 
GWAS Catalog 2019 241 
Database of Human Genotypes and Phenotypes (dbGaP) 136 
Disease Perturbations from GEO (Up-regulated genes) 204 
Disease Perturbations from GEO (Down-regulated genes) 240 
Rare Diseases GeneRIF Gene Lists 473 
Rare Diseases GeneRIF ARCHS4 Predictions 603 
Rare Diseases AutoRIF ARCHS4 Predictions 641 
Rare Diseases AutoRIF Gene Lists 1,116 
Legend: *, defined at adjusted p-value < 0.05; GEO, gene expression omnibus; GO, gene ontologies; GWAS, genome-
wide association studies; ARCHS4, all RNA-seq and ChIP-seq sample and signature search; KEGG, Kyoto Encyclopedia 
of Genes and Genomes; MGI, mouse genome informatics;
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Figure 1. GREAT analysis identifies 8,405 human genes associated with 35,074 human-specific single nucleotide changes (SNCs) 
in differentially accessible (DA) chromatin regions during human and chimpanzee brain development in cerebral organoids. 
A total of 1,064 of all 35,074 SNCs (3%) are not associated with any genes in the human genome, while a total of 34,010 human-
specific SNCs in DA regions appear associated with 8,405 human genes.
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Figure 2. Identification of genes expression of which distinguishes thousands of anatomically distinct areas of 
the adult human brain, various regions of the central nervous system, and many different cell types and tissues 
in the human body.  
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Figure 3. Identification and characterization of genes expression of which is altered during aging of humans, 
rats, and mice. 
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Figure 4. Identification of genes implicated in development and manifestations of hundreds physiological and 
pathological phenotypes and autosomal inheritance in Modern Humans. 
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Figure 5. Identification of genes expression of which is altered in several hundred common human disorders. 
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Figure 6. Identification of genes implicated in more than 1,000 records classified as human rare diseases. 
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Figure 7. Gene ontology analyses of putative regulatory targets of genetic loci harboring human-specific 
SNCs. 
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Figure 8. KEGG analyses of putative regulatory targets of genetic loci harboring human-specific SNCs. 
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Figure 9. Structurally, functionally, and evolutionary distinct classes of HSRS share the relatively restricted 
elite set of common genetic targets.  
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Figure 10. Interrogation of MGI Mammalian Phenotype databases identifies genes associated with human-
specific SNCs and implicated in premature death and embryonic, perinatal, neonatal, and postnatal lethality 
phenotypes. 
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Figure 11. Identification of 2,273 genes (offspring survival genes) associated with human-specific SNCs and 
implicated in premature death and embryonic, perinatal, neonatal, and postnatal lethality phenotypes. Bottom 
figure shows identification of offspring survival genes that were implicated in the autosomal dominant (389 
genes) and recessive (426 genes) inheritance in Modern Humans.  
